Report no. 94/2012

Amendment to a significant contract in the subsidiary company “Mikulicz” sp. z o.o. in Świebodzice

Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19 February 2009 on current and periodical information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A., in connection with receiving as of 7 September 2012  an annex to the contract concluded with the National Health Fund - the Dolnośląskie Voivodeship Branch in Wrocław (the Fund Branch) signed by the subsidiary company “Mikulicz” sp. z o.o. ) regarding healthcare services in the scope of  outpatient specialist care (cost-consuming outpatient diagnostic services) for the period from 1 January  to 31 December 2012.

Healthcare services referred to hereinabove are provided by the subsidiary company “Mikulicz” Sp. z o.o. in Świebodzice owned by EMC Instytut Medyczny S.A.

The Issuer informed about the contracts concluded by Mikulicz sp. z o.o. with the Fund Branch concerning rendering services in 2012 in its current report nos. 5/2012 of 20.01.2012, 16/2012 of 30.01.2012, 24/2012 of 15.02.2012, 52/2012 of 31.05.2012, 68/2012 of 02.07.2012, 74/2012 of 08.08.2012 and 89/2012 of 05.09.2012.

 As a result of signing the said annex, the total maximum Fund Branch liability towards the subsidiary company “Mikulicz” Sp. z o.o. in Świebodzice has changed and  it currently amounts to PLN 14,322,664.10 (a decrease by PLN 16,925.00) for the period from 1 January to 31 December 2012.

The other material terms of the contract with the highest value made public remain unchanged. A criterion for a contract to be considered significant: The value of contracts exceeds 10% of the Issuer’s equity capital.